Smart medication management system for patient-centric medicine optimisation

世卫组织报告称，50%的长期服药患者未能遵守规定的治疗方案。因此，不遵守药物治疗是一个严重的世界性问题，对治疗效果、患者福祉和医疗保健资源的使用产生负面影响。患者的不依从性每年使NHS损失超过5亿英镑。认识到解决这个问题的迫切需要，NHS致力于药物优化议程，采用更以患者为中心的方法，让患者从他们的药物中获得最佳效果。Protelhealth已经确定了一个通用智能药物管理系统的机会，该系统可以提供个性化的药物支持。它将通过集成现有系统和连接医疗保健生态系统中的各种利益相关者，为药物依从性提供简单、经济高效的解决方案，这些利益相关者的支持是提供以患者为中心的方法所必需的。它将增加独立性，避免再次住院，提高治疗效果并降低死亡率。

The WHO reports that 50% of patients who are prescribed medication for long-termconditions, fail to adhere to the prescribed regimen. As a result, non-adherence to medicationis a worldwide problem of striking magnitude, having a negative impact on the efficacy oftreatments, patients’ well-being and the use of healthcare resources. Patient non-adherencecosts the NHS more than £500 million every year. Recognising the pressing need to tackle theproblem, the NHS committed to the medicines optimisation agenda to adopt a more patientfocusedapproach for patients to get the best outcome from their medicines. Protelhealth haveidentified an opportunity for a universal smart medication management system, which candeliver personalised medication support. It will provide a simple, cost-effective solution tomedication adherence by integrating with and into existing systems and connecting thevarious stakeholders in the healthcare ecosystems whose support is necessary to provide apatient-centric approach. It will increase independence, avoid re-hospitalisation, improvetreatment effectiveness and reduce mortality.